National shareholder rights firm Hagens Berman is investigating Alignment Healthcare following a whistleblower lawsuit alleging systemic financial manipulation. The lawsuit, filed by former chief transformation officer Hakan Kardes, claims the company misclassified operating expenses as capital expenditures to inflate adjusted EBITDA for 2024 and 2025, boosting key performance metrics tied to stock price and executive compensation. Alignment Healthcare's stock fell approximately 16.7% in a single day after the allegations surfaced, marking its worst single-day performance since February 2024. The firm is examining whether Alignment Healthcare misled investors about its financial health and internal controls.
Alignment Healthcare LLCWhistleblower lawsuit alleging financial manipulation and investigation by law firm.